Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effectiveness of Antipsychotic Medications in Patients With Schizophrenia (CATIE Schizophrenia Trial)

NCT00014001 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.

NCT NCT00014001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00014001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effectiveness of Antipsychotic Medications in Patients With Schizophrenia (CATIE Schizophrenia Trial)
Lead sponsor
National Institute of Mental Health (NIMH)
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2000
Completion date
December 31, 2004
Enrollment
1,600
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia